HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

T Yasuno Selected Research

bis(1- N- oxide- pyridine- 2- thiolato)oxovanadium(IV)

6/2001Amelioration of insulin resistance in diabetic ob/ob mice by a new type of orally active insulin-mimetic vanadyl complex: bis(1-oxy-2-pyridinethiolato)oxovanadium(IV) with VO(S(2)O(2)) coordination mode.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


T Yasuno Research Topics

Disease

2Insulin Resistance
06/2001 - 10/2000
1Type 2 Diabetes Mellitus (MODY)
06/2001
1Glucose Intolerance
06/2001
1Obesity
06/2001

Drug/Important Bio-Agent (IBA)

2Glucose (Dextrose)FDA LinkGeneric
06/2001 - 10/2000
1Insulin (Novolin)FDA Link
06/2001
1bis(1- N- oxide- pyridine- 2- thiolato)oxovanadium(IV)IBA
06/2001
1Protein Tyrosine PhosphatasesIBA
06/2001
1bis(1- oxy- 2- pyridinethiolato)oxovanadium(IV)IBA
06/2001
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
06/2001
1Vanadates (Orthovanadate)IBA
06/2001
1Nonesterified Fatty Acids (NEFA)IBA
10/2000
1Triglycerides (Triacylglycerol)IBA
10/2000

Therapy/Procedure

1Aftercare (After-Treatment)
06/2001